Pfiz­er sub­mits trade­mark ap­pli­ca­tion that sug­gests it could be launch­ing a di­rect-to-pa­tient pro­gram

Pfiz­er may be the next phar­ma gi­ant to launch a di­rect-to-con­sumer plat­form.

The com­pa­ny ap­plied in April to trade­mark “Pfiz­er for All” for a num­ber …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.